Watchlist

Watchlist
ARCA biopharma, Inc. (ABIO)
ARCA biopharma, Inc. (ABIO)
ARCA Bio nabs European patent covering candidate AB171; shares ahead 25%
Thinly traded nano cap ARCA biopharma ( ABIO +25% ) jumps on a healthy 23x surge in volume in response to its announcement that the European Patent Office has issued it a new patent covering methods of treating cardiovascular disease and conditions with a thiol-substituted isosorbide mon…
Premarket Gainers as of 9:05 am
CADC +198% . More news on: China Advanced Construction Materials Group, Inc., SemiLEDs Corporation, Time Inc., Stocks on the move, Read more …
Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d…
ARCA biopharma reports Q3 results
ARCA biopharma (NASDAQ: ABIO ): Q3 EPS of -$0.39 Cash and equivalents of $16M Press Release More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
ARCA biopharma (ABIO) Presents At The Sidoti & Company Fall 2017 Convention - Slideshow
The following slide deck was published by ARCA biopharma, Inc. in conjunction with this Read more …
ARCA bio's mid-stage study of Gencaro in atrial fibrillation to continue as planned; shares ahead 9% after hours
Thinly traded nano cap ARCA biopharma (NASDAQ: ABIO ) is up 9% on increased volume on the news that the independent Data and Safety Monitoring Board (DSMB) has completed its pre-planned interim analysis of the company's Phase 2b clinical trial, GENETIC-AF, evaluating Gencaro (b…
ARCA bio slumps in mid-session trade, shares down 12%
Thinly traded nano cap ARCA biopharma ( ABIO -11.6% ) was treating water today until recent trading dropped shares as low as $1.90. Volume is below average so far. More news on: ARCA biopharma, Inc., Healthcare stocks news, Stocks on the move, Read more …
Daily Insider Ratings Round Up 7/17/17: IFF, OPK, MHH, MERC, NEP
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC yesterday. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Significant" in…
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial
Outcome of Phase 2B Interim Efficacy Analysis Anticipated in September 2017 80% of Phase 2B Planned Patient Enrollment Completed ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies fo…
ARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it will present a corporate overview at the Planet MicroCap Showcase 2017 Investor Conference…
ARCA biopharma reports FY results
ARCA biopharma (NASDAQ: ABIO ): FY EPS of -$1.81 Cash and equivalents of $23.51M Press Release More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
ARCA biopharma, Inc. (ABIO)